Result of general meeting

May 2, 2025 biodexa pharmaceuticals plc (“biodexa” or the “company”) result of general meeting biodexa pharmaceuticals plc, (nasdaq: bdrx), a clinical stage biopharmaceutical company developing a pipeline of innovative products for the treatment of diseases with unmet medical needs announces that at its general meeting held at 1.00pm bst today, ordinary resolutions 1 and 2 were passed by majorities of 62% and 61%, respectively. special resolution 3 failed to pass with a majority vote of 71%.
GM Ratings Summary
GM Quant Ranking